IBDEI3AE ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,52459,0)
 ;;=E10.10^^194^2539^18
 ;;^UTILITY(U,$J,358.3,52459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52459,1,3,0)
 ;;=3^DM Type 1 w/ Ketoacidosis w/o Coma
 ;;^UTILITY(U,$J,358.3,52459,1,4,0)
 ;;=4^E10.10
 ;;^UTILITY(U,$J,358.3,52459,2)
 ;;=^5002587
 ;;^UTILITY(U,$J,358.3,52460,0)
 ;;=E10.11^^194^2539^17
 ;;^UTILITY(U,$J,358.3,52460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52460,1,3,0)
 ;;=3^DM Type 1 w/ Ketoacidosis w/ Coma
 ;;^UTILITY(U,$J,358.3,52460,1,4,0)
 ;;=4^E10.11
 ;;^UTILITY(U,$J,358.3,52460,2)
 ;;=^5002588
 ;;^UTILITY(U,$J,358.3,52461,0)
 ;;=E10.21^^194^2539^8
 ;;^UTILITY(U,$J,358.3,52461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52461,1,3,0)
 ;;=3^DM Type 1 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,52461,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,52461,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,52462,0)
 ;;=E10.22^^194^2539^3
 ;;^UTILITY(U,$J,358.3,52462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52462,1,3,0)
 ;;=3^DM Type 1 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,52462,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,52462,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,52463,0)
 ;;=E10.29^^194^2539^24
 ;;^UTILITY(U,$J,358.3,52463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52463,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,52463,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,52463,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,52464,0)
 ;;=E10.311^^194^2539^12
 ;;^UTILITY(U,$J,358.3,52464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52464,1,3,0)
 ;;=3^DM Type 1 w/ Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,52464,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,52464,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,52465,0)
 ;;=E10.319^^194^2539^13
 ;;^UTILITY(U,$J,358.3,52465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52465,1,3,0)
 ;;=3^DM Type 1 w/ Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,52465,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,52465,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,52466,0)
 ;;=E10.3211^^194^2539^19
 ;;^UTILITY(U,$J,358.3,52466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52466,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,52466,1,4,0)
 ;;=4^E10.3211
 ;;^UTILITY(U,$J,358.3,52466,2)
 ;;=^5138279
 ;;^UTILITY(U,$J,358.3,52467,0)
 ;;=E10.3212^^194^2539^20
 ;;^UTILITY(U,$J,358.3,52467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52467,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,52467,1,4,0)
 ;;=4^E10.3212
 ;;^UTILITY(U,$J,358.3,52467,2)
 ;;=^5138280
 ;;^UTILITY(U,$J,358.3,52468,0)
 ;;=E10.3213^^194^2539^21
 ;;^UTILITY(U,$J,358.3,52468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52468,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,52468,1,4,0)
 ;;=4^E10.3213
 ;;^UTILITY(U,$J,358.3,52468,2)
 ;;=^5138281
 ;;^UTILITY(U,$J,358.3,52469,0)
 ;;=E10.39^^194^2539^26
 ;;^UTILITY(U,$J,358.3,52469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52469,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Ophth Compl
 ;;^UTILITY(U,$J,358.3,52469,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,52469,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,52470,0)
 ;;=E10.40^^194^2539^10
 ;;^UTILITY(U,$J,358.3,52470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52470,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,52470,1,4,0)
 ;;=4^E10.40
